Jennifer M Toye1, Lucia Mirea2, Junmin Yang2, Koravangattu Sankaran3
Division of Neonatology, Department of Pediatrics, University of Alberta, Edmonton, Canada
Trends in narcotics and sedative use during mechanical ventilation of preterm infants in Canadian neonatal intensive care units
Jennifer M Toye1, Lucia Mirea2, Junmin Yang2, Koravangattu Sankaran3
1. Division of Neonatology, Department of Pediatrics, University of Alberta, Edmonton;
2. Maternal-Infant Care Research Centre, Mount Sinai Hospital, Toronto;
3. Division of Neonatology, Department of Pediatrics, University of Saskatchewan, Saskatoon
Abstract：Objective Mechanical ventilation (MV) in preterm infants (PTI) causes discomfort. Whether it causes pain is controversial. Meta analysis reviews of published work on PTI during MV have shown no clinically significant impact of opioids on pain scales, and hence not recommended for routine use in neonatal intensive care units (NICUs). Similarly regular use of sedative midazolam is also not recommended. Therefore we hypothesized a downward trend in narcotics and sedatives used in MV of PTI in NICUs. This study aimed to assess trends of sedatives and narcotics use during MV of PTI in Canadian NICUs during 2004-2009.Methods PTI born at gestational age (GA) of < 35 weeks requiring invasive MV for > 24 hours were identified retrospectively from the Canadian Neonatal Network database for 2004-2009. PTI were excluded if moribund on admission, had major congenital anomalies, surgery (except laser eye surgery), necrotizing enterocolitis, chest tube or history of maternal narcotic abuse. PTI were classified according to whether they received any narcotics (morphine, fentanyl, methadone, sufentanyl, meperidine, alfentynl and codiene) or sedatives (chloral hydrate, midazolam, lorazepam, phenobarbital, pentobarbital, ketamine and propofol) for > 24 consecutive hours during MV. Trends of narcotics and sedatives were assessed using the Cochrane-Armitage Trend test separately for PTI born at < 29 and 29-34 weeks of GA.Results Among 5 638 study subjects, 2 169 (38.5%) received narcotics and 897 (15.9%) received sedatives. The most common narcotics were morphine (62.2%) and fentanyl (63.8%) and sedatives were phenobarbital (44.9%) and chloral hydrate (44.2%). A significant decreasing trend (P<0.01) in the use of any sedatives during MV was observed in PTI < 29 and 29-34 weeks of GA. However, the use of any narcotics during MV increased significantly (P=0.03) among PTI < 29 weeks of GA, and no change in trend was detected for PTI born at 29-34 weeks of GA.Conclusions The use of sedatives during MV in PTI born at < 35 weeks of GA was positively affected, however the narcotics use during MV remained constant for PTI born at 29-34 weeks, and increased in extremely low GA group (less than 29 weeks) suggesting evidence based practice change was not observed during the study period.
作者简介: Dr Jennifer M Toye, MD, FRCPC, MScPH, Assistant professor.
引用本文:
Jennifer M Toye,Lucia Mirea,Junmin Yang等. 加拿大新生儿重症监护病房早产儿机械通气期间麻醉镇痛药和镇静剂应用趋势的回顾性研究[J]. 中国当代儿科杂志, 2018, 20(1): 5-11.
Jennifer M Toye,Lucia Mirea,Junmin Yang et al. Trends in narcotics and sedative use during mechanical ventilation of preterm infants in Canadian neonatal intensive care units[J]. CJCP, 2018, 20(1): 5-11.
Anand KJ. Neonatal stress response to anesthesia and surgery[J]. Clin Perinatol, 1990, 17(1):207-214.
[2]
American Academy of Pediatrics Committee on Fetus and Newborn; American Academy of Pediatrics Section on Surgery; Canadian Paediatric Society Fetus and Newborn Committee, et al. Prevention and management of pain in the neonate:an update[J]. Pediatrics, 2006, 118(5):2231-2241.
[3]
Bellù R, de Waal KA, Zanini R. Opioids for neonates receiving mechanical ventilation[J]. Cochrane Database Syst Rev, 2008, (1):CD004212.
[4]
Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit[J]. Cochrane Database Syst Rev, 2012, (6):CD002052.
[5]
Bellù R, de Waal K, Zanini R. Opioids for neonates receiving mechanical ventilation:a systematic review and meta-analysis[J]. Arch Dis Child Fetal Neonatal Ed, 2010, 95(4):F241-F251.
[6]
Anand KJ, Barton BA, McIntosh N, et al. Analgesia and sedation in preterm neonates who require ventilatory support:results from the NOPAIN trial. Neonatal outcome and prolonged analgesia in neonates[J]. Arch Pediatr Adolesc Med, 1999, 153(4):331-338.
[7]
Harte GJ, Gray PH, Lee TC, et al. Haemodynamic responses and population pharmacokinetics of midazolam following administration to ventilated, preterm neonates[J]. J Paediatr Child Health, 1997, 33(4):335-338.
[8]
van Straaten HL, Rademaker CM, de Vries LS. Comparison of the effect of midazolam or vecuronium on blood pressure and cerebral blood flow velocity in the premature newborn[J]. Dev Pharmacol Ther, 1992, 19(4):191-195.
[9]
Lee SK, McMillan DD, Oholsson A, et al. Variations in practice and outcomes in the Canadian NICU network:1996-1997[J]. Pediatrics, 2000, 106(5):1070-1079.
[10]
Canadian Neonatal Network (CNN). Abstractor's Manual[S/OL].[May 20, 2017].
[11]
Granja C, Lopes A, Moreira S, et al. Patients' recollections of experiences in the intensive care unit may affect their quality of life[J]. Crit Care, 2005, 9(2):R96-R109.
Anand KJ, Hall RW. Pharmacological therapy for analgesia and sedation in the newborn[J]. Arch Dis Child Fetal Neonatal Ed, 2006, 91(6):F448-F453.
[14]
Knight M. Adverse drug reactions in neonates[J]. J Clin Pharmacol, 1994, 34(2):128-135.
[15]
Mayers DJ, Hindmarsh KW, Gorecki DK, et al. Sedative/hypnotic effects of chloral hydrate in the neonate:trichloroethanol or parent drug?[J]. Dev Pharmacol Ther, 1992, 19(2-3):141-146.
[16]
Laptook AR, Rosenfeld CR. Chloral hydrate toxicity in a preterm infant[J]. Pediatr Pharmacol (New York), 1984, 4(3):161-165.
[17]
Hall RW, Anand KJ. Pain management in newborns[J]. Clin Perinatol, 2014, 41(4):895-924.
[18]
Shankaran S, Cepeda EE, Ilagan N, et al. Antenatal phenobarbital for the prevention of neonatal intracerebral hemorrhange[J]. Am J Obstet Gynecol, 1986, 154(1):53-57.
[19]
Smit E, Odd D, Whitelaw A. Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants[J]. Cochrane Database Syst Rev, 2013, (8):CD001691.
[20]
Loepke AW. Developmental neurotoxicity of sedatives and anesthetics:a concern for neonatal and pediatric critical care medicine?[J]. Pediatr Crit Care Med, 2010, 11(2):217-226.
[21]
Kaija M, Metsarnta M, Vanhatalo S. Drug effects on endogenous brain activity in preterm babies[J]. Brain Dev, 2014, 36(2):116-123.
[22]
Benders MJ, Palmu K, Menache C, et al. Early brain activity relates to subsequent brain growth in premature infants[J]. Cereb Cortex, 2015, 25(9):3014-3024.
[23]
Shah PS, Dunn M, Lee SK, et al. Early opioid infusion and neonatal outcomes in preterm neonates ≤ 28 weeks' gestation[J]. Am J Perinatol, 2011, 28(5):361-366.
[24]
Hall RW, Kronsberg SS, Barton BA, et al. Morphine, hypotension, and adverse outcomes among preterm neonates:who's to blame? Secondary results from the NEOPAIN trial[J]. Pediatrics, 2005, 115(5):1351-1359.
[25]
Ferguson SA, Ward WL, Paule MG, et al. A pilot study of preemptive morphine analgesia in preterm neonates:effects on head circumference, social behavior, and response latencies in early childhood[J]. Neurotoxicol Teratol, 2012, 34(1):47-55.
[26]
MacGregor R, Evans D, Sugden D, et al. Outcome at 5-6 years of prematurely born children who received morphine as neonates[J]. Arch Dis Child Fetal Neonatal Ed, 1998, 79(1):F40-F43.
[27]
Zwicker JG, Miller SP, Grunau RE, et al. Smaller cerebellar growth and poorer neurodevelopmental outcomes in very preterm infants exposed to neonatal morphine[J]. J Pediatr, 2016, 172:81-87.
[28]
Steinhorn R, McPherson C, Anderson PJ, et al. Neonatal morphine exposure in very preterm infants-cerebral development and outcomes[J]. J Pediatr, 2015, 166(5):1200-1207.e4.
[29]
Barrington K. Premedication for endotracheal intubation in the newborn infant[J]. Paediatr Child Health, 2011, 16(3):159-171.
[30]
Fleishman R, Zhou C, Gleason C, et al. Standardizing morphine use for ventilated preterm neonates with a nursing-driven comfort protocol[J]. J Perinatol, 2015, 35(1):46-51.
[31]
Zimmerman KO, Smith PB, Benjamin DK, et al. Sedation, analgesia, and paralytics during mechanical ventilation of premature infants[J]. J Pediatr, 2017, 180:99-104.
[32]
McPherson C. Sedation and analgesia in mechanically ventilated preterm neonates:continue standard of care or experiment?[J]. J Pediatr Pharmacol Ther, 2012, 17(4):351-364.
